Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
OSE:AZT
Watchlist
Price: 14.2 NOK 1% Market Closed
Market Cap: 725.2m NOK
Have any thoughts about
Arcticzymes Technologies ASA?
Write Note

P/FCFE
Price to FCFE

-54.3
Current
78.3
Median
23.3
Industry
Lower than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
-54.3
=
Market Cap
720.1m NOK
/
FCFE
-13.3m NOK
All Countries
Close
Market Cap P/FCFE
NO
Arcticzymes Technologies ASA
OSE:AZT
720.1m NOK -54.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 238 155.5
US
Abbvie Inc
NYSE:ABBV
318.3B USD 12.8
US
Amgen Inc
NASDAQ:AMGN
139B USD 23.5
US
Gilead Sciences Inc
NASDAQ:GILD
113.7B USD 11.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.7B USD -78.4
US
Epizyme Inc
F:EPE
94.1B EUR -423.8
AU
CSL Ltd
ASX:CSL
138.5B AUD 78.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.9B USD 23.8
US
Seagen Inc
F:SGT
39.3B EUR -58.3
NL
argenx SE
XBRU:ARGX
36.6B EUR -114.5
 
NO
Arcticzymes Technologies ASA
OSE:AZT
Average P/FCFE: 29.9
Negative Multiple: -54.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -3 238 155.5
US
Abbvie Inc
NYSE:ABBV
12.8
US
Amgen Inc
NASDAQ:AMGN
23.5
US
Gilead Sciences Inc
NASDAQ:GILD
11.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -78.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -423.8
AU
CSL Ltd
ASX:CSL
78.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
23.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.3
NL
argenx SE
XBRU:ARGX
Negative Multiple: -114.5

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A